[go: up one dir, main page]

HN2001000039A - ACETISALICILIC ACID SOLUTIONS - Google Patents

ACETISALICILIC ACID SOLUTIONS

Info

Publication number
HN2001000039A
HN2001000039A HN2001000039A HN2001000039A HN2001000039A HN 2001000039 A HN2001000039 A HN 2001000039A HN 2001000039 A HN2001000039 A HN 2001000039A HN 2001000039 A HN2001000039 A HN 2001000039A HN 2001000039 A HN2001000039 A HN 2001000039A
Authority
HN
Honduras
Prior art keywords
acetisalicilic
acid solutions
solutions
acid
aas
Prior art date
Application number
HN2001000039A
Other languages
Spanish (es)
Inventor
Wolfgang Wiehl
Martina Wirtz
Dietmar Bahn
Original Assignee
Bayer Aftiengesellschft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aftiengesellschft filed Critical Bayer Aftiengesellschft
Publication of HN2001000039A publication Critical patent/HN2001000039A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A SOLUCIONES DE ACIDO ACETILSALICILICO (AAS) Y A AGENTES BASADOS EN ESTAS SOLUCIONES PARA EL TRATAMIENTOTOPICO DEL DOLOR.THE PRESENT INVENTION REFERS TO SOLUTIONS OF ACETILSALICILIC ACID (AAS) AND AGENTS BASED ON THESE SOLUTIONS FOR THE TOTAL TREATMENT OF PAIN.

HN2001000039A 2000-03-07 2001-03-05 ACETISALICILIC ACID SOLUTIONS HN2001000039A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10011032A DE10011032A1 (en) 2000-03-07 2000-03-07 Stable solutions of acetylsalicylic acid in mixture of organic solvent and water, useful for topical treatment of pain, especially pain associated with herpes zoster

Publications (1)

Publication Number Publication Date
HN2001000039A true HN2001000039A (en) 2001-07-09

Family

ID=7633806

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2001000039A HN2001000039A (en) 2000-03-07 2001-03-05 ACETISALICILIC ACID SOLUTIONS

Country Status (9)

Country Link
EP (1) EP1263441A2 (en)
AR (1) AR028237A1 (en)
AU (1) AU2001272099A1 (en)
DE (1) DE10011032A1 (en)
GT (1) GT200100035A (en)
HN (1) HN2001000039A (en)
PE (1) PE20030207A1 (en)
SV (1) SV2002000339A (en)
WO (1) WO2001066115A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070196460A1 (en) * 2004-02-16 2007-08-23 Yukiko Inamoto External preparation for treating skin or mucosal injury caused by viral infection
EP2023916B1 (en) 2006-05-02 2017-11-15 Pfeinsmith Ltd. Acidic composition
US11096949B2 (en) * 2017-05-30 2021-08-24 Rhoshan Pharmaceuticals, Inc. In-vial deposition of a stable, sterile and crystalline O-acetyl salicylic acid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
MX9602955A (en) * 1994-01-24 1997-06-28 Procter & Gamble PROCEDURE FOR SOLUBIZING HARDLY SOLUBLE PHARMACEUTICAL ASSETS.

Also Published As

Publication number Publication date
EP1263441A2 (en) 2002-12-11
WO2001066115A3 (en) 2002-02-14
SV2002000339A (en) 2002-06-07
PE20030207A1 (en) 2003-04-16
AU2001272099A1 (en) 2001-09-17
AR028237A1 (en) 2003-04-30
DE10011032A1 (en) 2001-09-13
GT200100035A (en) 2001-12-18
WO2001066115A2 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
HN2001000190A (en) SUSTAINED RELEASE FORMULATIONS FOR GROWTH HORMONE SECRETAGOGS
HN1999000015A (en) TREATMENT FOR A FEMALE SEXUAL DYSFUNCTION
HN2001000244A (en) SPIROPIRIMIDIN INHIBITORS - 2, 4, 6 - TRIONA METALOPROTEINASAS.
EE200400020A (en) Substituted oxazolidinones for combination therapy
HN1999000096A (en) INTRANASAL FORMULATIONS TO TREAT SEXUAL DISORDERS
PA8469401A1 (en) BICYCLE DERIVATIVES OF HYDROXAMIC ACID
AR026163A1 (en) USE OF RETIGABINE FOR THE TREATMENT OF NEUROPATIC PAIN
AR024944A1 (en) AMIDAS OF CARBOXILIC ACIDS, MEDICATIONS CONTAINING THESE COMPOUNDS, THEIR USE AND THEIR PREPARATION
HN1999000124A (en) SUBSTITUTED PYRAZOLE DERIVATIVES.
HN1997000110A (en) DERIVATIVES OF ARYLSULFOONYLAMINE HYDROXAMIC ACID
HN2001000217A (en) NEW TIADIAZOLS AND OXADIAZOLS AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE - 7
HN2002000110A (en) USE OF (Z) - 2 - CIANO - 3 - HYDROXY - BUTIL - 2 - ENOIC ACID (4 '- TRIFLUOROMETIL PHENYL) - AMIDA FOR THE TREATMENT OF MULTIPLE SCLEROSIS.
FI20000635A0 (en) Use of COMT inhibitors as an analgesic
DK1305037T3 (en) Painkiller
AR028772A1 (en) 5-AMINOALQUIL-PIRAZOL [4,3-D] PYRIMIDINS
SE0004101D0 (en) New use
HN2001000039A (en) ACETISALICILIC ACID SOLUTIONS
EA200200853A1 (en) APPLICATION OF 2-METHYL THIAZOLIDINE-3,3-DICARBONIC ACID (2-MTDK) AND / OR ITS PHYSIOLOGICAL COMPATIBLE SALTS FOR THE TREATMENT AND / OR CANCER PREVENTION
BR0010699A (en) Substituted benzimidazoles, their production and use as an agent against parasitic protozoa
ES2169399T3 (en) PROCEDURE TO PREPARE USEFUL FENYL CYCLES AS INHIBITORS OF COX-2.
HN2000000078A (en) AMIDAS REPLACED FENILCICLOHEXANOCARBOXILICO ACID AND ITS USE AS INHIBITORS OF ADENOSINE INCORPORATION
AR030945A1 (en) AMIDAS OF FENILCICLOHEXANOCARBOXILICO SUBSTITUTED ACID AND USE
UY26608A1 (en) SOLUTIONS OF ACETILSALICÍLICO ACID
GT200000114A (en) CRYSTALLINE FORM III OF THE N- (4- (5-DIMETHYLAMINOFTALEN-1-SULPHONYLAMINE) PHENYL) -3-HYDROXI-2, 2-DIMETHYLPROPIONAMIDE.
SE0300535D0 (en) Treatment of burns